Fast Market Research

MediPoint: Renal Denervation - Global Analysis and Market Forecasts - New Study Released

Fast Market Research recommends "MediPoint: Renal Denervation - Global Analysis and Market Forecasts" from GlobalData, now available

Repost This

Boston, MA -- (SBWIRE) -- 12/24/2013 -- Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure.

View Full Report Details and Table of Contents

While there is room for optimism and excitement, there are also significant barriers that the technology must overcome before it can see the widespread adoption that industry professionals want. One of the most threatening issues involves ambulatory blood pressure readings and how they could severely tarnish the purported impact the technology has on reducing blood pressure. Thus, a lot will depend on the quality of the data produced by the first randomized clinical trial from Medtronic in 2014, which includes this measure. Additionally, the current players in the market will have to face a bombardment of renal denervation systems from startup companies that harness slightly different technologies, offering advantages such as external denervation and non-generator-based systems. Compounding this competitive landscape are different device categories that aim to reduce blood pressure through completely different mechanisms, such as carotid baroreceptor stimulation.

As this market becomes more competitive, device makers are going to have to develop clinical differentiators for their systems or else this market will quickly become commoditized. Additionally, device manufacturers will have to seek additional indications for their systems to help the market continue to grow. In light of these impending challenges, GlobalData has produced a market research report, MediPoint: Renal Denervation - Global Analysis and Market Forecasts. Utilizing primary research with the leading adopters of the technology in the major global economies and industry executives from the major players in the market, as well as secondary research, this report offers a comprehensive analysis of the current and future marketplace for these devices.


Key Questions Answered

Companies Mentioned in this Report: Ablative Solutions, ApexNano, Best Medical International, Boston Scientific Corporation, Cardiosonic, Covidien, Cordis Corporation and Johnson & Johnson, Cryomend, Kona Medical, Medtronic, Mercator MedSystems, Northwind Medical, ReCor Medical, Sound Interventions, St. Jude Medical, Symple Surgical, Terumo Corporation, Verve Medical

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- MediPoint: Renal Denervation - EU Analysis and Market Forecasts
- MediPoint: Renal Denervation - APAC Analysis and Market Forecasts
- MediPoint: Renal Denervation - US Analysis and Market Forecasts
- MediPoint: Renal Denervation - South American Analysis and Market Forecasts
- MediPoint: Renal Denervation - Current and Future Players
- MediPoint: Total Shoulder Replacement - Global Analysis and Market Forecasts
- MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts
- MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts
- MediPoint: Total Shoulder Replacement - EU Analysis and Market Forecasts
- MediPoint: Drug-Eluting Balloons - Global Analysis and Market Forecasts